logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10857209 B1

PDFFull Text
Date of Patent:
Dec. 08, 2020

Filed:

Feb. 10, 2017

Lysosomal acid lipase and ppar gamma ligands as immune therapies for cancer treatment

Applicant:

Indiana University Research and Technology Corporation, Indianapolis, IN (US);

Inventors:

Cong Yan, Carmel, IN (US);

Hong Du, Carmel, IN (US);

Assignee:

Indiana University Research and Technology Corporation, Indianapolis, IN (US);

Attorney:

Stinson LLP

Primary Examiner:

Bin Shen

Int. Cl.
CPC ...
A61K 38/43 (2006.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); G01N 33/50 (2006.01); C12N 9/20 (2006.01); G01N 33/574 (2006.01); A61K 38/17 (2006.01); A61K 31/427 (2006.01); A61K 31/47 (2006.01); A61K 31/5575 (2006.01); A61K 38/46 (2006.01); A61K 45/06 (2006.01); A61K 31/4439 (2006.01); A61K 31/426 (2006.01); A61K 31/201 (2006.01); A61K 31/428 (2006.01); A61K 31/421 (2006.01);
U.S. Cl.
CPC ...
A61K 38/43 (2013.01); A61K 9/0019 (2013.01); A61K 31/201 (2013.01); A61K 31/421 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/4439 (2013.01); A61K 31/47 (2013.01); A61K 31/5575 (2013.01); A61K 38/1774 (2013.01); A61K 38/465 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C12N 9/20 (2013.01); C12Y 301/01013 (2013.01); G01N 33/5044 (2013.01); G01N 33/5743 (2013.01); G01N 33/57423 (2013.01); C12Y 301/01 (2013.01); G01N 2333/92 (2013.01);
Abstract

Methods of cancer treatment are disclosed. Particularly, disclosed herein are methods of administering LAL and PPARγ ligands for treating various cancer patients to promote anti-cancer immunity (suppress MDSC), use for inhibiting tumor progression, and use for inhibiting tumor metastasis.

Find Patent Forward Citations

Yan, Cong. (2020). Lysosomal acid lipase and ppar gamma ligands as immune therapies for cancer treatment (U.S. Patent No. 10857209). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10857209

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…